ReShape Lifesciences Inc
NASDAQ:RSLS
ReShape Lifesciences Inc
Net Income (Common)
ReShape Lifesciences Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ReShape Lifesciences Inc
NASDAQ:RSLS
|
Net Income (Common)
-$11.4m
|
CAGR 3-Years
3%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Income (Common)
$1.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
3%
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Income (Common)
$1.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Income (Common)
$3.2B
|
CAGR 3-Years
26%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
12%
|
|
Abbott Laboratories
NYSE:ABT
|
Net Income (Common)
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
9%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Income (Common)
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is ReShape Lifesciences Inc's Net Income (Common)?
Net Income (Common)
-11.4m
USD
Based on the financial report for Dec 31, 2023, ReShape Lifesciences Inc's Net Income (Common) amounts to -11.4m USD.
What is ReShape Lifesciences Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
21%
Over the last year, the Net Income (Common) growth was 75%. The average annual Net Income (Common) growth rates for ReShape Lifesciences Inc have been 3% over the past three years , 21% over the past five years .